Paracalcitol: cost benefits over calcitriol

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1579, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Esomeprazole offers benefits at low-to-no cost

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 598, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Comparative Cost-Benefit Analyses of Paricalcitol and Calcitriol in Stage 4 Chronic Kidney Disease from the Perspective of a Health Plan

By Gal-Moscovici Anca

Clinical Drug Investigation, Vol. 27, Iss. 2, 2007-01 ,pp. : 105-113

Adis International

Access to resources Recommend Favorite

Early initiation of irbesartan provides maximum cost benefits

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 460, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

High cost of dalteparin not worth added benefits in cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 476, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Adherence to antipsychotics low despite health, cost benefits

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite